B 
Becton Dickinson and Co BDX · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
215.25
+1.59%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$21.84bn
FY2016FY2025
Net income
$1.68bn
FY2016FY2025
Free cash flow
$2.67bn
FY2016FY2025
Shareholders' equity
$25.39bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.84bn | $20.18bn | $19.37bn | $18.87bn | $19.13bn | $16.07bn | $17.29bn | $15.98bn | $12.09bn | $12.48bn |
| Gross profit | $9.92bn | $9.13bn | $8.17bn | $8.48bn | $8.63bn | $6.80bn | $8.29bn | $7.27bn | $5.96bn | $5.99bn |
| Research and development | $1.26bn | $1.19bn | $1.24bn | $1.26bn | $1.28bn | $1.04bn | $1.06bn | $1.00bn | $770.0m | $828.0m |
| Operating income | $2.58bn | $2.40bn | $2.11bn | $2.28bn | $2.25bn | $912.0m | $1.76bn | $1.51bn | $1.50bn | $1.43bn |
| Net income | $1.68bn | $1.71bn | $1.48bn | $1.78bn | $2.09bn | $874.0m | $1.23bn | $311.0m | $1.10bn | $976.0m |
| Diluted earnings per share | 5.89 | 5.87 | 5.09 | 6.23 | 7.30 | 2.98 | 4.48 | 1.13 | 4.78 | 4.48 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $55.33bn | $57.29bn | $52.78bn | $52.93bn | $53.88bn | $54.01bn | $51.84bn | $53.90bn | $37.73bn | $25.59bn |
| Cash and short-term investments | $859.0m | $2.30bn | $1.42bn | $1.17bn | $2.40bn | $2.85bn | $566.0m | $1.16bn | $14.22bn | $1.91bn |
| Total liabilities | $29.94bn | $31.40bn | $26.98bn | $27.65bn | $30.20bn | $30.25bn | $30.68bn | $32.91bn | $24.79bn | $17.95bn |
| Debt | $19.18bn | $20.11bn | $15.88bn | $16.07bn | $17.61bn | $17.93bn | $19.39bn | $21.50bn | $18.87bn | $11.55bn |
| Shareholders' equity | $25.39bn | $25.89bn | $25.80bn | $25.28bn | $23.68bn | $23.77bn | $21.08bn | $20.99bn | $12.95bn | $7.63bn |
| Shares outstanding | 285m | 290m | 291m | 285m | 287m | 293m | 275m | 274m | 230m | 218m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $3.43bn | $3.80bn | $2.99bn | $2.63bn | $4.65bn | $3.54bn | $3.33bn | $2.87bn | $2.55bn | $2.56bn |
| Capital spending | −$760.0m | −$725.0m | −$874.0m | −$973.0m | −$1.23bn | −$810.0m | −$957.0m | −$895.0m | −$727.0m | −$718.0m |
| Free cash flow | $2.67bn | $3.07bn | $2.12bn | $1.66bn | $3.42bn | $2.73bn | $2.37bn | $1.97bn | $1.82bn | $1.84bn |
| Dividends paid | −$1.20bn | −$1.10bn | −$1.11bn | −$1.08bn | −$1.05bn | −$1.03bn | −$984.0m | −$927.0m | −$677.0m | −$562.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.98bn | $4.71bn | $5.25bn | $5.89bn | $5.51bn | $5.27bn | $5.17bn | $5.44bn |
| Gross profit | $2.31bn | $2.15bn | $2.34bn | $2.80bn | $2.63bn | $2.26bn | $2.23bn | $2.49bn |
| Operating income | $663.0m | $94.0m | $594.0m | $697.0m | $882.0m | $546.0m | $453.0m | $622.0m |
| Net income | $377.0m | −$311.0m | $382.0m | $493.0m | $574.0m | $308.0m | $303.0m | $400.0m |
| Diluted earnings per share | 1.37 | -1.13 | 1.34 | 1.73 | 2.01 | 1.08 | 1.04 | 1.38 |
| Cash from operations | $652.0m | $671.0m | $657.0m | $1.35bn | $1.22bn | $164.0m | $693.0m | $1.18bn |
| Capital spending | −$376.0m | −$125.0m | −$108.0m | −$352.0m | −$174.0m | −$129.0m | −$105.0m | −$296.0m |
| Free cash flow | $276.0m | $546.0m | $549.0m | $1.00bn | $1.04bn | $35.0m | $588.0m | $882.0m |
| Total assets | $50.73bn | $50.83bn | $54.84bn | $55.33bn | $54.90bn | $54.47bn | $54.66bn | $57.29bn |
| Cash and short-term investments | $709.0m | $816.0m | $1.03bn | $859.0m | $757.0m | $683.0m | $728.0m | $2.30bn |
| Debt | $16.81bn | $17.28bn | $19.54bn | $19.18bn | $19.34bn | $19.27bn | $18.76bn | $20.25bn |
| Shareholders' equity | $24.42bn | $24.13bn | $25.28bn | $25.39bn | $25.47bn | $25.24bn | $25.20bn | $25.89bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 5.0% | 6.3% | 7.8% |
| Operating income | 4.1% | 23.1% | 9.2% |
| Net income | -1.9% | 13.9% | 9.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 45.3% | 44.5% | 44.3% | 45.4% |
| Operating margin | 11.8% | 11.7% | 10.9% | 10.8% |
| Net margin | 8.1% | 8.3% | 8.3% | 7.6% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 33.0 | 38.6 | 47.9 | 40.8 | 34.5 | 83.9 | 60.6 | 198.7 | 44.8 | 36.9 |
| Price to sales | 2.5 | 3.3 | 3.7 | 3.9 | 3.8 | 4.6 | 4.3 | 3.9 | 4.1 | 2.9 |
Market value over time
29 Apr 2016 to 16 Sept 2026, in USD
$34.14bn$50.04bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | -13% | -7% | -3% | -2% | 2% | -9% | 25% | -1% | 32% | 12% |
Dividends and splits
Per share, in the currency the company pays
Paid for 52 years. Last went ex-dividend on 9 Sept 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 4.20 | 4.16 | 3.80 | 3.64 | 3.48 | 3.32 | 3.16 | 3.08 |
- 2-for-1 split · 21 Aug 1998
- 2-for-1 split · 16 Aug 1996
- 2-for-1 split · 1 Mar 1993
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.